Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Gross Profit: 2024-2025

Historic Gross Profit for Prime Medicine (PRME) over the last 2 years, with Sep 2025 value amounting to $1.2 million.

  • Prime Medicine's Gross Profit rose 486.12% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Prime Medicine reported Gross Profit of $1.2 million as of Q3 2025, which was up 9.87% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Gross Profit peaked at $2.2 million during Q4 2024, and registered a low of $209,000 during Q3 2024.
  • Its 2-year average for Gross Profit is $1.1 million, with a median of $1.2 million in 2025.
  • Data for Prime Medicine's Gross Profit shows a peak YoY soared of 486.12% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Prime Medicine's Gross Profit stood at $2.2 million in 2024, then spiked by 486.12% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.1 million for Q2 2025, and $1.5 million during Q1 2025.